Communication gaps complicate healthcare and can devastate the prognosis of a patient undergoing cancer treatment. Here are a few ways to overcome inconsistencies with cancer care delivery
Communication gaps complicate healthcare and can devastate the prognosis of a patient undergoing cancer treatment. Shared decisions on treatment are important, but can take on different meanings depending on what the patient might desire. Care navigation, integrated care, and accountable care delivery are a few approaches that can help tide over unnecessary gaps in cancer care and improve clinical, as well as financial outcomes.
1. Collaboration in the time of accountability
Where do we lack in cancer care today and what steps can we take to improve care delivery? According to Michael Kolodziej, MD, care coordination that involves the oncologist is key. The former national medical director for oncology at Aetna, writes that with healthcare moving toward integrated and accountable care, collaboration is the only path to clinical and financial success.
2. Emphasis on dialogue
Patient-centered care, shared decisions, and seamless care transitions in oncology would be impossible without adequate communication among care providers, patients, and family caregivers. By forcing oncologists to provide patients with a documented care plan, the Oncology Care Model is ensuring patients always have access to all the information they need to make informed care decisions. Panelists discussed this and more during a panel discussion on care gaps in oncology treatment.
3. The doctor—patient communication
The importance of doctor—patient communication is well established. Focus groups conducted with patients and oncologists help unravel why gaps exists and how to customize strategies for improvement. The National Coalition for Cancer Survivorship conducted an oncologist—patient focus group to identify the most effective approaches to improve communication and adoption of shared decision making. The results found significant gaps in a variety of care-related decisions.
4. Ensuring the success of innovation in the clinic
When innovative treatments are delivered to patients, the entire team needs to be on board—and this includes not just the care staff, but also the administrative staff. This was the message delivered at the recent Institute for Clinical Immuno-Oncology National Conference in Philadelphia. Novel treatments like the immuno-oncology agents are an unknown territory for everyone involved in patient care, and for successful clinical outcomes, open communication channels among the care team, the patient, and family members is essential. Also, a patient navigator can prove a very valuable resource for the patient, both during active treatment, as well as in the survivorship phase.
5. Bridging the care gap
CareSource is helping to bridge the gap in patient care by bringing together stakeholders with the patient’s care needs at the forefront of the conversation. Karin VanZant, executive director of Life Services at CareSource, told The American Journal of Managed Care® that her organization is working to bring together all resources and ensure that care providers follow a consistent plan.
Covered Preventive Services at Risk: V-BID Summit Breaks Down the Braidwood v Becerra Case
March 20th 2024For more than a decade, certain high-value preventive care services have been covered at no cost to patients under the Affordable Care Act, but a current legal challenge has the coverage at risk.
Read More
Oncology Onward: A Conversation With Penn Medicine's Dr Justin Bekelman
December 19th 2023Justin Bekelman, MD, director of the Penn Center for Cancer Care Innovation, sat with our hosts Emeline Aviki, MD, MBA, and Stephen Schleicher, MD, MBA, for our final episode of 2023 to discuss the importance of collaboration between academic medicine and community oncology and testing innovative cancer care delivery in these settings.
Listen
FDA Approves Tislelizumab for Advanced or Metastatic ESCC After Chemotherapy
March 15th 2024The FDA has approved tislelizumab-jsgr (Tevimbra) for single-agent use in adult patients with unresectable or metastatic esophageal squamous cell carcinoma following prior systemic chemotherapy that did not include a PD-1/PD-L1 inhibitor.
Read More
Oncology Onward: A Conversation With Thyme Care CEO and Cofounder Robin Shah
October 2nd 2023Robin Shah, CEO of Thyme Care, which he founded in 2020 with Bobby Green, MD, president and chief medical officer, joins hosts Emeline Aviki, MD, MBA, and Stephen Schleicher, MD, MBA, to discuss his evolution as an entrepreneur in oncology care innovation and his goal of positively changing how patients experience the cancer system.
Listen
Evolution of HDHPs With VBID Components Can Improve Care for Chronic Disease
March 14th 2024Over the course of the last 20 years, high-deductible health plans (HDHPs) have undergone an evolution. Today’s plans, with more high-value services covered predeductible, can improve care for people with chronic diseases, said panelists at the 2024 Value-Based Insurance Design (V-BID) Summit.
Read More
Fragmented Payer System, Vulnerable Supply Chain Among Threats to Accessing Essential Medicines
March 13th 2024During a session of the 2024 V-BID Summit, panelists Stacie Dusetzina, PhD, and Inma Hernandez, PharmD, PhD, discussed how access to essential medications is curtailed not just by the longstanding complexities of insurance design but also by emerging threats such as supply chain weaknesses and cyberattacks.
Read More